A drug with the SMILES Nc1ccc(-c2nc3cc(C(=O)O)ccc3n2CCCn2c(-c3ccc(F)cc3)nc3cc(C(F)(F)F)ccc32)cc1 has a human ether-à-go-go related gene (hERG) inhibition at 1uM of 10.937\%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_1uM__names__noun} of {herg_central_at_1uM#}{herg_central_at_1uM__units}.
Nc1ccc(-c2nc3cc(C(=O)O)ccc3n2CCCn2c(-c3ccc(F)cc3)nc3cc(C(F)(F)F)ccc32)cc1
Nc1ccc(-c2nc3cc(C(=O)O)ccc3n2CCCn2c(-c3ccc(F)cc3)nc3cc(C(F)(F)F)ccc32)cc1
2-(4-aminophenyl)-1-[3-[2-(4-fluorophenyl)-5-(trifluoromethyl)benzimidazol-1-yl]propyl]benzimidazole-5-carboxylic acid